Monaco Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Sell |
100,000
-125,000
| -56% | -$2.1M | 0.29% | 35 |
|
|
2025
Q1 | $3.46M | Buy |
+225,000
| New | +$3.46M | 0.71% | 13 |
|
|
2024
Q3 | – | Sell |
-475,000
| Closed | -$7.72M | – | 73 |
|
|
2024
Q2 | $7.72M | Sell |
475,000
-889,121
| -65% | -$14.4M | 1.23% | 8 |
|
|
2024
Q1 | $19.2M | Sell |
1,364,121
-3,179
| -0.2% | -$44.9K | 5.76% | 3 |
|
|
2023
Q4 | $14.3M | Sell |
1,367,300
-157,700
| -10% | -$1.65M | 4.2% | 4 |
|
|
2023
Q3 | $15.6M | Buy |
1,525,000
+590,587
| +63% | +$6.02M | 4.61% | 3 |
|
|
2023
Q2 | $7.04M | Buy |
+934,413
| New | +$7.04M | 1.96% | 8 |
|
|
2023
Q1 | – | Sell |
-75,000
| Closed | -$684K | – | 80 |
|
|
2022
Q4 | $684K | Sell |
75,000
-59,000
| -44% | -$538K | 0.21% | 50 |
|
|
2022
Q3 | $1.08M | Buy |
+134,000
| New | +$1.08M | 0.41% | 40 |
|